Crohn's Disease Clinical Trials

30 trials recruiting in Canada.

Digestive Health

Recruiting Drug Device Behavioral Older adults Healthy volunteers

17 trials

Testing IV Tulisokibart against a placebo for Crohn's disease

Explore this study →

Sites in London, Montreal and 13 more cities

Official title: A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Crohn's Disease · Merck Sharp & Dohme LLC

Comparing 3 approaches for Crohn's disease

Explore this study →

Sites in Edmonton, London and 5 more cities

RecruitingPHASE4

Official title: A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Crohn's Disease · Takeda

Comparing Mirikizumab - with LY4395089 for crohn disease

Explore this study →

Sites in Lethbridge, London and 1 more city

RecruitingPHASE2

Official title: A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Crohn Disease · Eli Lilly and Company

Get matched to the best-fit trials

Answer a few questions and we'll find the closest matches for crohn's disease.

Comparing Guselkumab with Risankizumab for crohn disease

Explore this study →

Sites in Montreal, Edmonton and 5 more cities

RecruitingPHASE3

Official title: A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease · Janssen Research & Development, LLC

Testing Duvakitug against a placebo for Crohn's disease

Explore this study →

Sites in Hamilton and Toronto

RecruitingPHASE3

Official title: A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease · Sanofi

Testing Duvakitug against a placebo for Crohn's disease

Explore this study →

Sites in Brampton, Edmonton and 5 more cities

RecruitingPHASE3

Official title: An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease · Sanofi

Testing Mirikizumab for crohn disease

Explore this study →

Sites in London, Scarborough Village and 1 more city

RecruitingPHASE4

Official title: Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Crohn Disease · Alimentiv Inc.

Testing Afimkibart against a placebo for moderately to severely active crohns disease

Explore this study →

Sites in London, Barrie and 3 more cities

RecruitingPHASE3

Official title: A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease · Hoffmann-La Roche

Testing Afimkibart against a placebo for moderately to severely active crohns disease

Explore this study →

Sites in Edmonton, Trois-Rivières and 1 more city

RecruitingPHASE3

Official title: A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Moderately to Severely Active Crohns Disease · Hoffmann-La Roche

Testing SAR441566 against a placebo for Crohn's disease

Explore this study →

Sites in Calgary, Montreal and 1 more city

RecruitingPHASE2

Official title: A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.

Crohn's Disease · Sanofi

Comparing 7 approaches for Crohn's disease

Explore this study →

Sites in Edmonton, Calgary and 5 more cities

RecruitingPHASE2

Official title: Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Crohn's Disease · AbbVie

Comparing KleanLyte with Bi-PegLyte for crohn disease

Explore this study →

One site, in Winnipeg

RecruitingPHASE4

Official title: Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.

Crohn Disease · University of Manitoba

Comparing 4 approaches for Crohn's disease

Explore this study →

Sites in London, Montreal and 4 more cities

RecruitingPHASE2

Official title: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Crohn's Disease · Takeda

Testing Vedolizumab against a placebo for Crohn's disease

Explore this study →

Sites in Barrie, Calgary and 7 more cities

RecruitingPHASE3

Official title: A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease

Crohn's Disease · Takeda

Comparing Tirzepatide with Mirikizumab for Crohn's disease

Explore this study →

Sites in London, Vancouver and 3 more cities

RecruitingPHASE3

Official title: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's Disease · Eli Lilly and Company

Comparing JNJ-78934804 with Guselkumab for crohn disease

Explore this study →

Sites in Edmonton, Montreal and 5 more cities

RecruitingPHASE3

Official title: A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease · Janssen Research & Development, LLC

Testing Icotrokinra against a placebo for crohn disease

Explore this study →

Sites in Barrie, Edmonton and 6 more cities

RecruitingPHASE2

Official title: A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease · Janssen Research & Development, LLC

Looking for the closest fit?

Get matched →

Get notified when a matching trial opens

We'll watch for Crohn's Disease trials near you.

← Back to all conditions

Concord provides information support only. Trial listings come from public registries; eligibility is always determined by the trial site and your care team.